Tetraploidy, a condition in which a cell has four homologous sets of chromosomes, is often seen as a natural physiological condition but is also frequently seen in pathophysiological conditions such as cancer. Tetraploidy facilitates chromosomal instability (CIN), which is an elevated level of chromosomal loss and gain that can cause production of a wide variety of aneuploid cells that carry structural and numerical aberrations of chromosomes. The resultant genomic heterogeneity supposedly expedites karyotypic evolution that confers oncogenic potential in spite of the reduced cellular fitness caused by aneuploidy. Recent studies suggest that tetraploidy might also be associated with aging; mice with mutations in an intermediate filament protein have revealed that these tetraploidy-prone mice exhibit tissue disorders associated with aging. Cellular senescence and its accompanying senescence-associated secretory phenotype have now emerged as critical factors that link tetraploidy and tetraploidy-induced CIN with cancer, and possibly with aging. Here, we review recent findings about how tetraploidy is related to cancer and possibly to aging, and discuss underlying mechanisms of the relationship, as well as how we can exploit the properties of cells exhibiting tetraploidy-induced CIN to control these pathological conditions.
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| INTRODUCTION
Ploidy is the number of complete sets of chromosomes in the cell.
Eukaryotes generally have two sets, as pairs of homologous chromosomes, and this situation is referred to as diploidy. However, there are occasions in which cells have more than two sets of chromosomes and this is called polyploidy. Both diploid and polyploid cells can also have multiples of one complete (haploid) set of chromosomes, collectively called euploidy. In contrast, aneuploidy is a deviation from a multiple of the haploid chromosome number in which some of the chromosomes are missing or present in excess. Aneuploidy is generally considered a pathological condition, which is seen in most cancer cells and also suggested to be implicated in aging. 1 Polyploidy, however, is not necessarily a pathological condition and can sometimes be seen in physiological conditions. Polyploidy is commonly seen in plants, and some specific mammalian cell types become polyploid during terminal differentiation, for example, megakaryocytes in the bone marrow and trophoblasts in the placenta. 2, 3 Tetraploidy is a type of polyploidy in which a single cell has four sets of chromosomes. Tetraploidy is formed from diploid cells
through mechanisms such as cell fusion, endoreduplication, mitotic slippage, or cytokinetic failure, the latter two being the main routes ( Figure 1 ). 2, 3 Mitotic slippage is a phenomenon in which mitotic cells enter the next cell cycle without undergoing chromosome segregation and cell division ( Figure 2A ). The timing of chromosome segregation is regulated by the spindle assembly checkpoint (SAC), which halts chromosome segregation until all the chromosomes establish biorientation, that is the attachment of kinetochores on replicated chromosomes (sister chromatids) to microtubules from opposite spindle poles (Figure 2A ). 4 Mitotic slippage occurs when the SAC-dependent mitotic arrest is sustained due to problems in biorientation establishment. It also happens when the SAC is defective. Cytokinetic failure occurs when the cleavage furrow formation or resolution is disturbed, resulting in binucleated cells ( Figure 2B ). It is known that the chromosomes left at the spindle center when chromosome segregation occurs due to defective kinetochore-microtubule attachments, known as lagging chromosomes, can disturb cleavage furrow formation, and cause cytokinetic failure ( Figure 2B ).
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Tetraploidy is a balanced state in terms of gene dosage, in contrast to aneuploidy, which is accompanied by unbalanced expression of genes on the affected chromosomes. 6 Tetraploidy is commonly seen in a subset of hepatocytes and cardiomyocytes in physiological conditions. 7, 8 Nevertheless, it is an uncommon and unfavorable event in other somatic cells; tetraploid fetuses inevitably result in spontaneous miscarriages. 2, 9 It has been shown that tetraploidization facilitates oncogenic transformation and cancer progression. 3 Furthermore, our unique mouse model has also suggested an unprecedented link between tetraploidy and aging. 10, 11 In this review, we will introduce the emerging relationship of tetraploidy with cancer and its possible association with aging, and discuss its role in the pathogenesis of these states as well as potential therapeutic strategies for their control by exploiting the properties of tetraploid cells.
| TETRAPLOIDY AND CANCER
It has been reported that approximately 26% of solid tumors show tetraploid or near-tetraploid karyotypes. 12 Based on bioinformatic analyses, whole-genome doubling is estimated to occur in a significant proportion of representative solid tumors (range, 11%-64%; overall average,~37%). 13 This event is highly associated with copy number aberration 13, 14 and poor prognosis. 15, 16 Under in vitro cultivation, tetraploid cells often develop into aneuploid cells. [17] [18] [19] [20] Chromosomal instability (CIN), a condition in which chromosome missegregation occurs at high rates, underlies the appearance of aneuploid cells, and recent data suggest that CIN resulting from tetraploidy, but not tetraploidy itself, plays a major role in oncogenesis ( Figure 1 ).
One important cause of CIN in tetraploid cells is the increase in the number of centrosomes. 21, 22 The centrosome is the main micro- Genomic heterogeneity caused by CIN accelerates karyotypic evolution that confers tumorigenic potential. However, aneuploidy is generally detrimental to cellular fitness, leading to apoptosis or cellular senescence. Cellular senescence is primarily an anticancer mechanism, but senescent cells increase in number with age, and this might contribute to tissue disorders associated with aging by compromising functionality and reducing the regenerative potential. Secretion of various pro-inflammatory proteins from senescent cells, referred to as the senescence-associated secretory phenotype (SASP), also promotes both tissue disorders and tumorigenesis. It was recently shown that senescent cells show stem cell-like gene expression patterns and exert aggressive growth potential following release from senescence. 95 TANAKA ET AL.
| 2633
Another reason for the prevalence of CIN in tetraploid cells is their tolerance to aneuploidy compared to diploid cells. 3, 16 Aneuploidy is generally disruptive to cellular fitness due to severe imbalances in gene expression. 6 The detrimental effect of gene 20 Also, tetraploidization confers the ability of non-transformed cells to form tumors in grafted mice. 17, 19, 40 These above effects are probably mediated by tetraploidy-induced aneuploidization, 17, 19, 20, 39 suggesting that tetraploidy in oncogenic cells results in karyotypic complexity in the cell population. 41, 42 In One mechanism is through the formation of micronuclei, which are compartmentalized chromosome masses isolated from the main nucleus ( Figure 3B ). Common origins for micronuclei are lagging chromosomes resulting from merotelic attachment. Chromosomes in micronuclei are subjected to DNA damage due to a defective nuclear membrane of the micronuclei, and fragmented DNAs are lost or erroneously ligated in the next cell cycle ( Figure 3B ). This is considered to be one of the mechanisms generating chromothripsis, which is characterized by extensive genomic rearrangements confined to one or few chromosomal regions. 46 Chromosomal instability also promotes DNA damage and genomic instability by several mechanisms, such as cleavage furrow ingression in the presence of lagging chromosomes and telomere deprotection during prolonged mitotic arrest. 47, 48 The idea that genomic heterogeneity caused by CIN facilitates oncogenesis and cancer progression fits well with the cancer clonal evolution model first proposed by Peter Nowell, 49 a theory similar to Darwinian natural selection. 50 Sequencing of whole cancer genomes has revealed that chromosomal regions enriched in oncogenes tend to be amplified, whereas those enriched in tumor suppressor genes tend to be lost. 51 The aforementioned stochastic model recapitulated Figure 4A ,B).
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As the IF protein vimentin is expressed in all mesenchymal cells, with the eye lens being the tissue containing by far the highest levels, 52,53,60 we produced genetically modified mice in which vimentin mutated at mitosis-specific phosphorylation sites is expressed instead of WT vimentin. 10 In these phosphodeficient mice, unscheduled binucleation (tetraploidization) is induced in cells in which vimentin is highly expressed, such as lens epithelial cells 10 and subcutaneous fibroblastic/adipose cells. 11 The level of p53 is elevated in these tetraploid cells, 11 suggesting that the p53 pathway likely functions in these mice. However, in the phosphodeficient mice, the tetraploid cells continue to divide and develop aneuploidy, 
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In support of our observations in the tetraploidy-prone mice, the population of tetraploid cells is elevated at several organs during normal aging. 68, 69 For example, some hepatocytes increase their ploidy, becoming tetraploid and octoploid, during the aging process. 70, 71 In the liver, some polyploid cells are likely to develop into aneuploid ones. 12 The phenotypes of our mice resemble those of aneuploidy-prone mice such as BubR1-hypomorphic 61 or Bub3/Rae1-haploinsufficient 72 mice. Therefore, tetraploidization contributes to progeroid phenotype probably through aneuploidization. It should be noted, however, that it has not been evaluated in detail whether tetraploid cells increase with age in other organs in general.
The link between tetraploidy and cellular senescence is also suggested in zebrafish, an attractive animal model for various human diseases including cancer 73 and age-related disorders. 74 It has been reported that tetraploid cardiomyocytes increase in prevalence with age and that cardiomyocyte regeneration is lost with age in mammals. 75, 76 A recent report verified the relationship between tetraploidy and cardiomyocyte regeneration in zebrafish by inhibiting epithelial cell transforming sequence 2 oncogene (ECT2), a major player in cytokinesis regulated by Rho GTPases 77 and in DNA damage responses. 78 Knockdown of ECT2 induced senescence markers in a spontaneously immortalized non-transformed mammary epithelial cell line with a KRAS mutation. 79 In adult zebrafish, transient inhibition of Ect2 increased tetraploidy in the heart and inhibited regeneration after apical ventricular resection. 80 These findings suggest that increased tetraploidy of cardiomyocytes and resultant decreased regeneration is a phenotype related to cellular senes- 3 days postfertilization. 83 The results are consistent with the functional role of condensin in the regulation of chromosomal organization of mitotic cells. 81 The results are also consistent with previous reports showing that tetraploidization can induce apoptosis. 36 These results suggest that apoptosis in the retina of developing zebrafish is one of the phenotypes caused by unscheduled tetraploidy that may be related to cellular senescence.
| TETRAPLOIDY-INDUCED TISSUE DISORDERS AND CANCER
Tetraploidy is found in various human tissues with varying frequencies that can be greater than those of chromosome missegregation. immune response, which is triggered by dsDNA, derived from pathogens, in the cytoplasm. 87 In cells showing CIN, an origin of fragmented DNA that can activate the cGAS-STING pathway is the DNA in micronuclei that is exposed to the cytoplasm due to nuclear membrane collapse ( Figure 3B) , 88, 89 which occurs in more than half of the micronuclei. 90 Cytoplasmic chromatin fragments released from nuclei through the disintegrated nuclear membrane after DNA damage in senescent cells can also activate the pathway. 91 The cGAS-STING pathway promotes the SASP program and triggers inflammation in senescence and cancer. Another report has shown that CIN also facilitates cancer metastasis through SASP induction by fragmented DNA in micronuclei. 92 These findings suggest an important role for CIN in cancer and tissue disorders associated with aging through SASP induction. proteins provide an opportunity to dissect the effects of tetraploidy on disorders associated with aging in different tissues. 56 The reason why tetraploidy is both beneficial and detrimental for cellular fitness, depending on cellular context, is also an important unanswered question. For the treatment of cancer, tetraploidy and CIN are promising targets for selective therapy, and clarifying the complicated relationship between CIN, cancer, and aging is crucial for developing optimal anticancer strategies as well as for mitigating aging-related disorders.
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